GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,643.00p
   
  • Change Today:
      3.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 878,899
  • Market Cap: £68,100m
  • RiskGrade: 129

News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
New Research Shows Many Patients with Persistent... 28-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire the Leading Dry Mouth... 21-Oct-2008 PR Newswire
GSK Notice of Third Quarter 2008 Results Announc... 20-Oct-2008 PR Newswire
LF Elimination Program Treats Over Half Billion ... 07-Oct-2008 PR Newswire
alli(TM) Partners with Breast Cancer Network of ... 22-Sep-2008 PR Newswire
MultiVu Video Feed: NEW BRAIN IMAGING SHOWS THE ... 18-Sep-2008 PR Newswire
GSK and XenoPort Announce Submission of New Drug... 16-Sep-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire
GSK Receives Decision From FDA on Advair(R) 500/... 08-Aug-2007 PR Newswire
GlaxoSmithKline Receives New HHS Order for H5N1 ... 03-Aug-2007 PR Newswire
FDA Issues Second Approvable Letter for Trexima(... 02-Aug-2007 PR Newswire
GlaxoSmithKline Presents Avandia Data To FDA 30-Jul-2007 PR Newswire
FDA Advisory Panel Votes 22 to 1 for Avandia(R) ... 30-Jul-2007 PR Newswire
ChemoCentryx Achieves $5 Million Milestone from ... 24-Jul-2007 PR Newswire
GSK's Cervical Cancer Candidate Vaccine Cervarix... 18-Jul-2007 PR Newswire
Pharmacopeia Advances First Therapeutic Program ... 17-Jul-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,643.00p
Change Today 3.50p
% Change 0.21 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 878,899
Shares Issued 4,144.88m
Market Cap £68,100m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
81.12% below the market average81.12% below the market average81.12% below the market average81.12% below the market average81.12% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Price Trend
32.95% above the market average32.95% above the market average32.95% above the market average32.95% above the market average32.95% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
43.54% above the market average43.54% above the market average43.54% above the market average43.54% above the market average43.54% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
25.73% below the market average25.73% below the market average25.73% below the market average25.73% below the market average25.73% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 23-Apr-2024

Time Volume / Share Price
13:01 301 @ 1,643.00p
13:01 286 @ 1,643.00p
13:01 469 @ 1,643.00p
13:01 171 @ 1,643.00p
13:01 184 @ 1,643.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page